Sep 2026· Atherosclerosis· pp.
121900
· 1 citation· 23 references
Medicine
TL;DR
In secondary prevention after PCI, AUC-derived cumulative LDL-C exposure was associated with MACCE beyond available baseline clinical characteristics and may complement snapshot LDL-C assessment.
Abstract
Background
AND
Aims
We assessed whether AUC-derived cumulative low-density lipoprotein cholesterol (LDL-C) exposure after percutaneous coronary intervention (PCI) was associated with subsequent major adverse cardiac and cerebrovascular events (MACCE), and compared this longitudinal metric with the latest LDL-C measurement.
Methods
We conducted a retrospective, single-centre, matched case-control study of consecutive patients undergoing successful PCI from 2010 to 2020. Cases with major adverse cardiac and cerebrovascular events (MACCE) were matched 1:1 to event-free controls by follow-up duration. Cumulative LDL-C exposure was calculated from serial LDL-C measurements by the trapezoidal rule. Conditional logistic regression with restricted cubic splines was used, with prespecified multivariable adjustment for available baseline clinical characteristics.
Results
Among 544 matched pairs, cumulative LDL-C exposure was higher in MACCE cases than controls (median 489.8 vs 179.5 mg/dL·year; p < 0.001), whereas the latest LDL-C was modestly lower in cases (74.3 ± 26.6 vs 81.2 ± 26.4 mg/dL; p < 0.001). In the multivariable-adjusted spline model, the odds ratio at 400 mg/dL·year was 2.73 (95% CI, 2.24-3.32) relative to the median exposure in controls. Associations were consistent in time-truncated and component-specific exploratory analyses.
Conclusions
In secondary prevention after PCI, AUC-derived cumulative LDL-C exposure was associated with MACCE beyond available baseline clinical characteristics and may complement snapshot LDL-C assessment. The apparent 400 mg/dL·year range is exploratory and hypothesis-generating, not a clinically actionable treatment target.
Although eCLE does not improve discrimination beyond age and LDL-C entered separately, it is a simple and practical metric that may be useful for risk stratification of cardiovascular events after ACS.
Naoki Serikawa, M. Yoshikawa, Hiroyuki Arashi et al.· International Journal of Car...· 0 citations
Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk, which may help identify patients with residual lipid-related risk in STEMI patients after primary PCI.
Qian-Ying Xie, Chao-Yi Wang, Wen-Jing Zhao et al.· Frontiers in Cardiovascular...· 0 citations
Achievement of LDL-C <55 mg/dL within 6 months after AMI is independently associated with a meaningful reduction in recurrent ASCVD events in real-world practice, and the temporal mismatch between early post-discharge risk and delayed lipid assessment underscores the need for proactive, multidisciplinary care models to...
Henry C. Okoroike, Wei-Li Zheng, Faisal Hasan et al.· American Journal of Cardiolo...· 0 citations
Dysregulated serum lipids and hyperglycemia are established risk factors for adverse outcomes in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). The Cholesterol, HDL, Glucose (CHG) index is a novel composite metric integrating glycemic and lipid profiles; however, its prognost...
Zai-Qiang Liu, Yu-Xiu Yang, Qiu-Xuan Li et al.· Scientific Reports· 0 citations
It is suggested that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population of patients with chronic coronary syndrome after percutaneous coronary intervention (PCI).
Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al.· Biomarkers in Medicine· 0 citations
OBJECTIVE
Young patients with myocardial infarction (MI) remain at risk for recurrent cardiovascular events despite favorable short-term outcomes. The prognostic significance of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio in this population remains insuff...
M. Keten, Kadir Bıyıklı· Türk Kardiyoloji Derneği a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.